The ready uptake of cesium and rubidium by the cancer cells lead the writer to the High pH therapy. This consists of feeding the patient close to
6 g of CsCl or RbCl per day in conjunction with the administration of ascorbic and retionic acids, Vitamins C and A, which being weak acids, upon
absorption by the tumor cells will enhance the negative potential gradient across the membrane, and also zinc and selenium salts which, when
absorbed on the membrane surface, will act as broad and moderately strong electron donors. Both types of compounds have been shown in
mice to drastically enhance the pickup for cesium and rubidium ions.
The toxic dose for CsCl is 135 g. The administration of 6 g per day therefore has no toxic effects. It is sufficient however to give rise to the pH in
the cancer cells, bringing them up in a few days to the 8 or above where the life of the cell is short. In addition, the presence of Cs and Rb salts
in the body fluids neutralizes the acid toxins leaking out of the tumor mass and renders them nontoxic.
TESTS OF THE HIGH pH THERAPY ON MICE AND HUMANS
The therapy has been tested and the results will be discussed briefly below.
Tests on Mice
The High pH therapy was first tested at American University in Washington, DC using mice. In these tests, 2 mm cubes of mammary tumors
were implanted in the abdomens of mice and allowed to grow for 8 days.
The mice were then divided into two groups. Both groups were continued on mouse chow, but the test group was given 1.11 g of rubidium
carbonate by mouth per day in aqueous solution.
After 13 more days the controls were starting to die so all mice were sacrificed and the tumors removed and weighed. The tumors in the test
animals weighed only one eleventh of those in the controls. In addition, the test animals were showing none of the adverse effects of
having cancer.
Results similar to those mentioned above were obtained at Platteville, WI using CsCl. More recently, Platteville has studied intraperitoneal
injection of cesium carbonate for mice with abdominal tumor implants with 97% curative effect.
Tests using intraperitoneal injections of CsCl were carried out by Messiha et al. The results were most successful and showed a drastic
shrinkage in the tumor masses.
Tests on Man
Many tests on humans have been carried out by H. Nieper in Hannover, Germany and by H. Sartori in Washington, DC as well as by a number of
other physicians. On the whole, the results have been very satisfactory. It has been observed that all pains associated with cancer disappear
within 12 to 24 hr, except in a very few cases where there was a morphine withdrawal problem that required a few more hours. In these tests 2 g
doses of CsCl were administered three times per day after eating. In most cases 5 to 10 g of Vitamin C and 100,000 units of Vitamin A, along with
50 to 100 mg of zinc, were also administered. Both Nieper and Sartori were also administering nitrilosides in the form of laetrile. There are good
reasons to believe that the laetrile may be more effective than the vitamins in enhancing the pickup of cesium by the cells.
In addition to the loss of pains, the physical results are a rapid shrinkage of the tumor masses. The material comprising the tumors is secreted as
uric acid in the urine; the uric acid content of the urine increases many fold. About 50% of the patients were pronounced terminal, and were not
able to work. Of these, a majority have gone back to work.
Two side effects have been observed in some of the patients. These are first nausea, and the second diarrhea. Both depend upon the
general condition of the digestive tract. Nieper feels that nausea can be prevented by administering the cesium in a solution of sorbitol. The
diarrhea may, to some extent, be affected by the Vitamin C.
Only one case history will be presented here.
A woman with 2 hard tumor masses 8 to 10 cm in diameter, one on her thyroid and one on her chest, was given 3 to 6 months to live. She had
been subjected to chemotherapy, but was discontinued because it weakened her. She was taking laetrile on her own. She was given a 50 g
bottle of CsCl and was told to take 4 g per day. She reported her case a year later. Being very frightened she took the entire 50 g in one week.
At the end of that time the tumor masses were very soft, so she obtained another 50 g of CsCl and took it in another week. By the end of that
time she could not find the tumors, and two years later there was no sign of their return. "
Additional Links
Dr. H.E. Sartori - Cesium therapy in cancer patients : 50 terminal cancer patients success rate of 50%
Neal Deoul Story - Cesium Chloride protocol: Refused surgery for prostate cancer and used high pH Therapy instead
6 g of CsCl or RbCl per day in conjunction with the administration of ascorbic and retionic acids, Vitamins C and A, which being weak acids, upon
absorption by the tumor cells will enhance the negative potential gradient across the membrane, and also zinc and selenium salts which, when
absorbed on the membrane surface, will act as broad and moderately strong electron donors. Both types of compounds have been shown in
mice to drastically enhance the pickup for cesium and rubidium ions.
The toxic dose for CsCl is 135 g. The administration of 6 g per day therefore has no toxic effects. It is sufficient however to give rise to the pH in
the cancer cells, bringing them up in a few days to the 8 or above where the life of the cell is short. In addition, the presence of Cs and Rb salts
in the body fluids neutralizes the acid toxins leaking out of the tumor mass and renders them nontoxic.
TESTS OF THE HIGH pH THERAPY ON MICE AND HUMANS
The therapy has been tested and the results will be discussed briefly below.
Tests on Mice
The High pH therapy was first tested at American University in Washington, DC using mice. In these tests, 2 mm cubes of mammary tumors
were implanted in the abdomens of mice and allowed to grow for 8 days.
The mice were then divided into two groups. Both groups were continued on mouse chow, but the test group was given 1.11 g of rubidium
carbonate by mouth per day in aqueous solution.
After 13 more days the controls were starting to die so all mice were sacrificed and the tumors removed and weighed. The tumors in the test
animals weighed only one eleventh of those in the controls. In addition, the test animals were showing none of the adverse effects of
having cancer.
Results similar to those mentioned above were obtained at Platteville, WI using CsCl. More recently, Platteville has studied intraperitoneal
injection of cesium carbonate for mice with abdominal tumor implants with 97% curative effect.
Tests using intraperitoneal injections of CsCl were carried out by Messiha et al. The results were most successful and showed a drastic
shrinkage in the tumor masses.
Tests on Man
Many tests on humans have been carried out by H. Nieper in Hannover, Germany and by H. Sartori in Washington, DC as well as by a number of
other physicians. On the whole, the results have been very satisfactory. It has been observed that all pains associated with cancer disappear
within 12 to 24 hr, except in a very few cases where there was a morphine withdrawal problem that required a few more hours. In these tests 2 g
doses of CsCl were administered three times per day after eating. In most cases 5 to 10 g of Vitamin C and 100,000 units of Vitamin A, along with
50 to 100 mg of zinc, were also administered. Both Nieper and Sartori were also administering nitrilosides in the form of laetrile. There are good
reasons to believe that the laetrile may be more effective than the vitamins in enhancing the pickup of cesium by the cells.
In addition to the loss of pains, the physical results are a rapid shrinkage of the tumor masses. The material comprising the tumors is secreted as
uric acid in the urine; the uric acid content of the urine increases many fold. About 50% of the patients were pronounced terminal, and were not
able to work. Of these, a majority have gone back to work.
Two side effects have been observed in some of the patients. These are first nausea, and the second diarrhea. Both depend upon the
general condition of the digestive tract. Nieper feels that nausea can be prevented by administering the cesium in a solution of sorbitol. The
diarrhea may, to some extent, be affected by the Vitamin C.
Only one case history will be presented here.
A woman with 2 hard tumor masses 8 to 10 cm in diameter, one on her thyroid and one on her chest, was given 3 to 6 months to live. She had
been subjected to chemotherapy, but was discontinued because it weakened her. She was taking laetrile on her own. She was given a 50 g
bottle of CsCl and was told to take 4 g per day. She reported her case a year later. Being very frightened she took the entire 50 g in one week.
At the end of that time the tumor masses were very soft, so she obtained another 50 g of CsCl and took it in another week. By the end of that
time she could not find the tumors, and two years later there was no sign of their return. "
Additional Links
Dr. H.E. Sartori - Cesium therapy in cancer patients : 50 terminal cancer patients success rate of 50%
Neal Deoul Story - Cesium Chloride protocol: Refused surgery for prostate cancer and used high pH Therapy instead
| The High pH Therapy excerpted from article by Keith Brewer, PhD. |
 | |  | |  | |  | |  | |  | |  | |  |
| The science supporting Cesium Chloride Protocol |